Advances in the antibody detection and immunotherapy of neutralizing antibodies for 2019-nCoV
10.3760/cma.j.cn114452-20200508-00457
- VernacularTitle:新型冠状病毒抗体检测及中和性抗体免疫治疗研究进展
- Author:
Mengjiao YUAN
;
Beili WANG
;
Baishen PAN
;
Wei GUO
- From:
Chinese Journal of Laboratory Medicine
2021;44(3):265-269
- CountryChina
- Language:Chinese
-
Abstract:
A novel coronavirus (COVID-19) that broke out in December 2019 has been declared a public health emergency of international concern. Nucleic acid detection has an irreplaceable role in the diagnosis of 2019-novel coronavirus (2019-nCoV) infection. However, due to the high requirements of laboratories and technicians, cumbersome operations, and the possibility of omission, nucleic acid detection should be combined with specific antibodies to achieve large-scale screening of suspected patients and close contacts. Moreover, antibody detection can reduce the exposure risk of medical personnel during the collection of respiratory tract samples.
